Alzheimer's disease: A healthcare burden of epidemic proportion

Thiruvinvamalai S. Dharmarajan, Srinivas G. Gunturu

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Alzheimer's disease is the most common cause of dementia and increases in prevalence exponentially with age, with trends in the United States likely to worsen in ensuing decades. The pathology in Alzheimer's disease is characterized by an increase in extracellular amyloid plaques and intraneural neurofibrillary tangles, with neuronal destruction in several areas of the brain, and biochemically by a deficiency in acetylcholine; clinical manifestations include progressive loss of memory, change in personality, and behavioral disturbances. Pharmacotherapy includes the use of cholinesterase inhibitors and memantine; addressing the many behavioral manifestations of the disease, especially in advanced stages, imposes tremendous burden to caregivers and healthcare resources.

Original languageEnglish (US)
Pages (from-to)39-47
Number of pages9
JournalAmerican Health and Drug Benefits
Volume2
Issue number1
StatePublished - 2009

Fingerprint

Alzheimer Disease
Memantine
Delivery of Health Care
Neurofibrillary Tangles
Cholinesterase Inhibitors
Amyloid Plaques
Memory Disorders
Caregivers
Acetylcholine
Personality
Dementia
Pathology
Drug Therapy
Brain
Burden
Alzheimer's disease
Proportion
Healthcare
Inhibitor
Resources

ASJC Scopus subject areas

  • Health Policy
  • Strategy and Management

Cite this

Alzheimer's disease : A healthcare burden of epidemic proportion. / Dharmarajan, Thiruvinvamalai S.; Gunturu, Srinivas G.

In: American Health and Drug Benefits, Vol. 2, No. 1, 2009, p. 39-47.

Research output: Contribution to journalArticle

@article{bfb08387ddd04734ade987da3e8e597a,
title = "Alzheimer's disease: A healthcare burden of epidemic proportion",
abstract = "Alzheimer's disease is the most common cause of dementia and increases in prevalence exponentially with age, with trends in the United States likely to worsen in ensuing decades. The pathology in Alzheimer's disease is characterized by an increase in extracellular amyloid plaques and intraneural neurofibrillary tangles, with neuronal destruction in several areas of the brain, and biochemically by a deficiency in acetylcholine; clinical manifestations include progressive loss of memory, change in personality, and behavioral disturbances. Pharmacotherapy includes the use of cholinesterase inhibitors and memantine; addressing the many behavioral manifestations of the disease, especially in advanced stages, imposes tremendous burden to caregivers and healthcare resources.",
author = "Dharmarajan, {Thiruvinvamalai S.} and Gunturu, {Srinivas G.}",
year = "2009",
language = "English (US)",
volume = "2",
pages = "39--47",
journal = "American Health and Drug Benefits",
issn = "1942-2962",
publisher = "Engage Healthcare Communications, Inc.",
number = "1",

}

TY - JOUR

T1 - Alzheimer's disease

T2 - A healthcare burden of epidemic proportion

AU - Dharmarajan, Thiruvinvamalai S.

AU - Gunturu, Srinivas G.

PY - 2009

Y1 - 2009

N2 - Alzheimer's disease is the most common cause of dementia and increases in prevalence exponentially with age, with trends in the United States likely to worsen in ensuing decades. The pathology in Alzheimer's disease is characterized by an increase in extracellular amyloid plaques and intraneural neurofibrillary tangles, with neuronal destruction in several areas of the brain, and biochemically by a deficiency in acetylcholine; clinical manifestations include progressive loss of memory, change in personality, and behavioral disturbances. Pharmacotherapy includes the use of cholinesterase inhibitors and memantine; addressing the many behavioral manifestations of the disease, especially in advanced stages, imposes tremendous burden to caregivers and healthcare resources.

AB - Alzheimer's disease is the most common cause of dementia and increases in prevalence exponentially with age, with trends in the United States likely to worsen in ensuing decades. The pathology in Alzheimer's disease is characterized by an increase in extracellular amyloid plaques and intraneural neurofibrillary tangles, with neuronal destruction in several areas of the brain, and biochemically by a deficiency in acetylcholine; clinical manifestations include progressive loss of memory, change in personality, and behavioral disturbances. Pharmacotherapy includes the use of cholinesterase inhibitors and memantine; addressing the many behavioral manifestations of the disease, especially in advanced stages, imposes tremendous burden to caregivers and healthcare resources.

UR - http://www.scopus.com/inward/record.url?scp=77953429975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953429975&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:77953429975

VL - 2

SP - 39

EP - 47

JO - American Health and Drug Benefits

JF - American Health and Drug Benefits

SN - 1942-2962

IS - 1

ER -